BUPRAMYL 20 MICROGRAMS/HOUR TRANSDERMAL PATCH
Active substance(s): BUPRENORPHINE / BUPRENORPHINE / BUPRENORPHINE
Bupramyl 5 micrograms/hour,
10 micrograms/hour and
Read all of this leaflet carefully before you start using this
medicine because it contains important information for you.
• Keep this leaflet. You may need to read it again.
• If you have any further questions, ask your doctor or
• This medicine has been prescribed for you only. Do not pass it
on to others. It may harm them, even if their signs of illness are
the same as yours.
• If you get any side effects, talk to your doctor or pharmacist.
This includes any possible side effects not listed in this leaflet.
See section 4.
What is in this leaflet
What Bupramyl is and what it is used for
What you need to know before you use Bupramyl
How to use Bupramyl
Possible side effects
How to store Bupramyl
Contents of the pack and other information
1. What Bupramyl is and what it is used for
Bupramyl contain the active ingredient buprenorphine which
belongs to a group of medicines called strong analgesics or
‘painkillers’. It has been prescribed for you by your doctor to relieve
moderate, long-lasting pain that requires the use of a strong
Bupramyl should not be used to relieve acute pain.
2. What you need to know before you use Bupramyl
Do not use Bupramyl:
if you are allergic to buprenorphine or any of the other ingredients of this medicine (listed in section 6)
if you have breathing problems
if you are addicted to drugs
if you are taking a type of medicine known as a monoamine oxidase inhibitor (examples include
tranylcypromide, phenelzine, isocarboxazid, moclobemide and linezolid), or you have taken this type of
medicine in the last two weeks
• if you suffer from myasthenia gravis (a condition in which the muscles become weak)
• if you have previously suffered from withdrawal symptoms such as agitation, anxiety, shaking or
sweating upon stopping taking alcohol.
Bupramyl must not be used to treat symptoms associated with drug withdrawal.
Warnings and precautions
• Bupramyl must not be used together with a type of medicine known as a monoamine oxidase inhibitor
(examples include tranylcypromide, phenelzine, isocarboxazid, moclobamide and linezolid), or if you
have taken this type of medicine in the last two weeks.
• If you take some medicines such as phenobarbital or phenytoin (medicines commonly used to treat
seizures, fits or convulsions), carbamazepine (a medicine to treat seizures, fits or convulsions and
certain pain conditions), or rifampicin (a medicine to treat tuberculosis) the effects of Bupramyl may be
• Bupramyl may make some people feel drowsy, sick or faint or make them breathe more slowly or
weakly. These side effects may be made worse if other medicines that produce the same effects are
taken at the same time. These include certain medicines to treat pain, depression, anxiety, psychiatric
or mental disorders, medicines to help you sleep, medicines to treat high blood pressure such as
clonidine, other opioids (which may be found in painkillers or certain cough mixtures e.g. morphine,
dextropropoxyphene, codeine, dextromethorphan, noscapine), antihistamines which make you drowsy,
or anaesthetics such as halothane.
• Bupramyl must be used with caution if you are also taking benzodiazepines (medicines used to treat
anxiety or to help you sleep). This combination may cause serious breathing problems.
Pregnancy, breast-feeding and fertility
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your
doctor or pharmacist for advice before using this medicine.
There is not sufficient experience regarding the use of buprenorphine in pregnant women. Therefore you
should not use Bupramyl if you are pregnant or if you could become pregnant during treatment.
Buprenorphine, the active substance contained in the transdermal patch, may inhibit milk formation and
passes into the breast milk. Therefore, you should not use Bupramyl if you are breast-feeding.
Driving and using machines
Bupramyl may affect your reactions to such an extent that you may not react adequately or quickly
enough in the event of unexpected or sudden occurrences. This applies particularly:
• at the beginning of treatment
• if you are taking medicines to treat anxiety or help you sleep
• if your dose is increased.
If you are affected (e.g. feel dizzy, drowsy or have blurred vision), you should not drive or operate
machinery whilst using Bupramyl, or for 24 hours after removing the patch.
3. How to use Bupramyl
Always use this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or
pharmacist if you are not sure.
Different strengths of Bupramyl are available. Your doctor will decide which strength of Bupramyl will suit
During treatment, your doctor may change the patch you use to a smaller or larger one if necessary. Do
not cut or divide the patch or use a higher dose than recommended. You should not apply more than two
patches at the same time.
If you feel that the effect of the Bupramyl is too weak or too strong, talk to your doctor or pharmacist.
Adults and elderly patients
Children and adolescents
Bupramyl should not be used in patients below the age of 18 years.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Alcohol may make some of the side effects worse and you may feel unwell if you drink alcohol whilst
wearing Bupramyl. Drinking alcohol whilst using Bupramyl may also affect your reaction time.
Unless your doctor has told you differently, attach one Bupramyl patch (as described in detail below) and
change it every seventh day, preferably at the same time of day. Your doctor may wish to adjust the dose
after 3-7 days until the correct level of pain control has been found. If your doctor has advised you to take
other painkillers in addition to the patch, strictly follow the doctor’s instructions, otherwise you will not
fully benefit from treatment with Bupramyl. The patch should be worn for 3 full days before increasing the
dose, this is when the maximum effect of a given dose is established.
Other medicines and Bupramyl
• Choose an area of non-irritated,
intact skin on your upper arm, outer
arm, upper chest, upper back or
side of the chest (see illustrations
besides). Ask for assistance if you
cannot apply the patch yourself.
Bupramyl with alcohol
Talk to your doctor or pharmacist before using Bupramyl:
• if you suffer from seizures, fits or convulsions
• if you have a severe headache or feel sick due to a head injury or increased pressure in your skull (for
instance due to brain disease). This is because the patches may make symptoms worse or hide the
extent of a head injury
• if you are feeling light-headed or faint
• if you have severe liver problems
• if you have ever been addicted to drugs or alcohol
• if you have a high temperature, as this may lead to larger quantities of the active ingredient being
absorbed into the blood than normal.
If you have recently had an operation, please speak to your doctor before using these patches.
Athletes should be aware that this medicine may cause a positive reaction to sports doping control tests.
Do not give this medicine to children and adolescents below 18 years.
Before applying the transdermal patch
• Bupramyl should be applied to a relatively hairless or nearly hairless skin site. If no suitable hair free
sites are available the hairs should be cut off with a pair of scissors. Do not shave them off.
• Avoid skin which is red, irritated or has any other blemishes, for instance large scars.
• The area of skin you choose must be dry and clean. If necessary, wash it with cold or lukewarm water.
Do not use soap, alcohol, oil, lotions or other detergents. After a hot bath or shower, wait until your
skin is completely dry and cool. Do not apply lotion, cream or ointment to the chosen area. This might
prevent your patch from sticking properly.
Applying the transdermal patch
• Step 1: Each transdermal patch is sealed in a sachet. Just before
use, cut the sachet along the sealed edge with scissors. Take out
the transdermal patch. Do not use the patch if the sachet seal is
Patients with kidney disease/dialysis patients
In patients with kidney disease, no change in dose is necessary.
Patients with liver disease
In patients with liver disease, the effects and period of action of Bupramyl may be affected and your
doctor will therefore check on you more closely.
Patients under 18 years of age
Method of administration
Bupramyl is for transdermal use.
Bupramyl acts through the skin. After application, buprenorphine passes through the skin into the blood.
• Step 2: The sticky side of the transdermal patch is covered
with a transparent protective foil. Carefully peel off one part of
the foil. Try not to touch the sticky part of the transdermal patch.
• Step 3: Stick the transdermal patch on to the area of skin you
have chosen and remove the remaining foil.
The pain relieving effect of Bupramyl is maintained for some time after removal of the patch. You should
not start another opioid analgesic (strong painkiller) within 24 hours after removal of the patch.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
4. Possible side effects
• Step 4: Press the transdermal patch against your skin with the
palm of your hand / and count slowly to 30. Make sure that the
whole transdermal patch is in contact with your skin, especially
at the edges.
Wearing the transdermal patch
You should wear the patch for seven days. Provided that you have applied the patch correctly, there is
little risk of it coming off. If the edges of the patch begin to peel off, they may be taped down with a
suitable skin tape. You may shower, bathe or swim whilst wearing it.
Do not expose the patch to extreme heat (e.g. heating pads, electric blanket, heat lamps, sauna, hot tubs,
heated water beds, hot water bottle, etc) as this may lead to larger quantities of the active ingredient
being absorbed into the blood than normal. External heat may also prevent the patch from sticking
properly. If you have a high temperature this may alter the effects of Bupramyl (see “Warnings and
Precautions” section above).
In the unlikely event that your patch falls off before it needs changing, do not use the same patch again.
Stick a new one on straight away (see “Changing the transdermal patch” below).
Changing the transdermal patch
• Take the old transdermal patch off.
• Fold it in half with the sticky side inwards.
• Open and take out a new patch. Use the empty sachet to dispose of the old patch. Now discard the
• Stick a new transdermal patch on a different appropriate skin site (as described above). You should not
apply a new patch to the same site for 3-4 weeks.
• Remember to change your patch at the same time of day. It is important that you make a note of the
time of day.
Duration of treatment
Your doctor will tell you how long you should be treated with Bupramyl. Do not stop treatment without
consulting a doctor, because your pain may return and you may feel unwell (see also “If you stop using
If you use more Bupramyl than you should
As soon as you discover that you have used more patches than you should, remove all patches and call
your doctor or hospital straight away. People who have taken an overdose may feel very sleepy and sick.
They may also have breathing difficulties or lose consciousness and may need emergency treatment in
hospital. When seeking medical attention make sure that you take this leaflet and any remaining patches
with you to show to the doctor.
If you forget to use Bupramyl
Stick a new patch on as soon as you remember. Also make a note of the date, as your usual day of
changing may now be different. If you are very late changing your patch, your pain may return. In this
case, please contact your doctor.
Do not apply additional patches to make up for the forgotten application.
If you stop using Bupramyl
If you stop using Bupramyl too soon or you interrupt your treatment your pain may return. If you wish to
stop treatment please consult your doctor. They will tell you what can be done and whether you can be
treated with other medicines.
Some people may have side effects when they have used strong painkillers for a long time and stop using
them. The risk of having effects after stopping Bupramyl is very low. However, if you feel agitated, anxious,
nervous or shaky, if you are overactive, have difficulty sleeping or digestive problems, tell your doctor.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Serious side effects that may be associated with buprenorphine are similar to those seen with other
strong painkillers and include difficulty in breathing and low blood pressure.
This medicine can cause allergic reactions, although serious allergic reactions are rare. Remove the patch
and tell your doctor immediately if you get any sudden wheeziness, difficulties in breathing, swelling of
the eyelids, face or lips, rash or itching especially those covering your whole body.
There is a risk that you may become addicted or reliant on Bupramyl.
In patients treated with Bupramyl, the following other side effects have been reported:
Very common (may affect more than 1 in 10 people):
• headache, dizziness, drowsiness
• constipation, feeling or actually being sick
• itchy skin, redness
• rash, redness, itching, inflammation or swelling of the skin at the application site.
Common (may affect up to 1 in 10 people):
• loss of appetite
• confusion, depression, anxiety, difficulty in sleeping, nervousness, shaking (tremors)
• shortness of breath
• abdominal pain or discomfort, diarrhoea, indigestion, dry mouth
• sweating, rash, skin eruptions
• tiredness, a feeling of unusual weakness, muscle weakness, oedema (e. g. swelling of hands, ankles or
Uncommon (may affect up to 1 in 100 people):
• sleep disorder, restlessness, agitation, a feeling of extreme happiness, affect liability, hallucinations,
nightmares, decreased sexual drive
• changes in taste, difficulty in speaking, reduced sensitivity to pain or touch, tingling or numbness
• loss of memory, migraine, fainting, problems with concentration or co-ordination
• dry eyes, blurred vision
• a ringing or buzzing sound in the ears, a feeling of dizziness or spinning
• high or low blood pressure, circulatory collapse, chest pain, fast or irregular heartbeat
• cough, hiccups, wheezing
• weight loss
• dry skin, urticaria, dermatitis contact
• spasms, aches and pains
• difficulty in beginning the flow of urine
• inability to fully empty the bladder
• weariness, oedema
• fever, chills
• local allergic reaction with marked signs of swelling (in such cases treatment should be stopped)
• flushing of the skin
• an increase in accidental injuries (e.g. falls)
• withdrawal symptoms such as agitation, anxiousness, sweating or shaking upon stopping using
If you need to have blood tests remind your doctor that you are using Bupramyl. This is important
because Bupramyl may change the way your liver works and this could affect the results of some blood
Rare (may affect up to 1 in 1,000 people):
• angina (chest pain associated with heart disease)
• mental disorder
• difficulties with balance
• visual disturbance, swelling of the eyelids or face, a reduction in size of the pupils in the eye
• difficulty in breathing, worsening of asthma, over breathing
• a feeling of faintness, especially on standing up
• difficulty in swallowing, ileus
• swelling and irritation inside the nose
• decreased erection, sexual dysfunction
• a flu like illness
Very rare (may affect up to 1 in 10,000 people):
• mood swings, drug dependence
• muscle twitching
• ear pain
Not known (frequency cannot be estimated from the available
• seizures, fits or convulsions
• inflammation of the bowel wall. Symptoms may include fever,
vomiting and stomach pain or discomfort
• colicky abdominal pain or discomfort
• feeling detached from oneself.
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This
includes any possible side effects not listed in this leaflet. You can
also report side effects directly via the Yellow Card Scheme at:
www.mhra.gov.uk/yellowcard. By reporting side effects, you can
help provide more information on the safety of this medicine.
5. How to store Bupramyl
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and sachet after EXP. The
expiry date refers to the last day of that month.
5 micrograms/h & 10 micrograms/h: Do not store above 25°C.
20 micrograms/h: This medicine does not require any special storage conditions.
Do not use the patch if the sachet seal is broken.
Used patches must be folded over on themselves with the adhesive layer inwards, and discarded safely.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw
away medicines you no longer use. These measures will help protect the environment.
6. Contents of the pack and other information
What Bupramyl patches contain
The active substance is buprenorphine.
• 5 micrograms/h: Each transdermal patch contains 5 mg of buprenorphine in a patch size of 6.25 cm2 and
releases 5 micrograms of buprenorphine per hour (over a period of 7 days).
• 10 micrograms/h: Each transdermal patch contains 10 mg of buprenorphine in a patch size of
12.5 cm2 and releases 10 micrograms of buprenorphine per hour (over a period of 7 days).
• 20 micrograms/h: Each transdermal patch contains 20 mg of buprenorphine in a patch size of
25 cm2 and releases 20 micrograms of buprenorphine per hour (over a period of 7 days).
The other ingredients are:
Adhesive matrix (containing buprenorphine): povidone K90, levulinic acid, oleyl oleate, Poly[acrylic acidco-butylacrylate-co-(2-ethylhexyl)acrylate-co-vinylacetate] (5:15:75:5)
Adhesive matrix (without buprenorphine): Poly[(2-ethylhexyl)acrylate-co-glycidylmethacrylate-co-(2hydroxyethyl)acrylate-co-vinylacetate] (68:0,15:5:27),
Separating foil between adhesive matrices with and without buprenorphine: polyethylene terephthalate
Backing foil: polyester.
Release liner: polyethylene terephthalate film, siliconized.
Blue printing ink.
What Bupramyl look like and contents of the pack
Three sizes are available.
• 5 micrograms/h: Rectangular beige coloured patch with rounded edges and imprinted with
“Buprenorphin” and “5 μg/h” in blue colour.
• 10 micrograms/h: Rectangular beige coloured patch with rounded edges and imprinted with
“Buprenorphin” and “10 μg/h” in blue colour.
• 20 micrograms/h: Rectangular beige coloured patch with rounded edges and imprinted with
“Buprenorphin” and “20 μg/h ” in blue colour.
One transdermal patch is sealed in one child-resistant sachet. The patches are available in cartons
containing 2, 4, 8 or 12 transdermal patches.
Not all pack sizes may be marketed.
Marketing Authorisation Holder
Mylan, Potters Bar, Hertfordshire, EN6 1TL, United Kingdom
Gerard Laboratories, Unit 35/36 Baldoyle Industrial Estate, Grange Road, Dublin 13, Ireland
This leaflet was last revised in 09/2016
Source: Medicines and Healthcare Products Regulatory Agency
Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.